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Abstract 
 
Diabetic retinopathy is a disease involving microangiopathic changes in response to chronic hyperglycaemia and pan 
retinal photocoagulation (PRP) is currently the mainstay of treatment for proliferative retinopathy. In the present 
study, we evaluated the effect of pan retinal photocoagulation (PRP) on retinal nerve fibre layer (RNFL) thickness in 
patients with diabetic retinopathy using optical coherence tomography (OCT). This was a prospective longitudinal 
study. Patients with Type 2 diabetes mellitus with proliferative diabetic retinopathy (PDR) or very severe non-
(N)PDR requiring laser treatment were included in the study. PRP was performed by a single trained personnel. 
Peripapillary RNFL located 3.4 mm around the optic disc was evaluated using time-domain OCT. Examination was 
performed before treatment, and 2 and 4 months after laser treatment. In total, 39 subjects (39 eyes) were recruited 
into this study. Twenty-nine patients had PDR and 10 had very severe NPDR. Mean age was 54.97 ± 8.38 years. 
Male and female genders were almost equally distributed with 18 males and 21 females. Median thickness of 
average RNFL at baseline was 108.8 um (interquartile range [IQR] 35.3). At two months post-procedure, average 
RNFL thickness significantly increased to 117.4 (IQR 28.6; P = 0.006). Although, other quadrants revealed a similar 
trend of increasing thickness at two months but it was not significant. At 4 months post-laser treatment, RNFL 
thickness in all quadrants reduced to baseline levels with insignificant changes of thickness compared to prior to 
laser treatment. There was also no significant association between changes in RNFL thickness and HbA1c levels (P 
= 0.77). In conclusion, PRP causes transient thickening of the RNFL which recovers within 4 months post-laser 
treatment. At the same time, poor sugar control has no direct influence on the RNFL changes after PRP. 
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Introduction 
 
Diabetic retinopathy is a disease involving 
microangiopathic changes in response to chronic 
hyperglycaemia. It is characterized by progressive 
dysfunction of retinal microvasculature, including 
microvascular occlusion and microvascular leakage 
(1). Successful management of diabetic retinopathy via 
the combination of glucose control, laser therapy, and 
vitrectomy represents one of the most striking 
achievements of modern ophthalmology. Routine 
fundus examinations initiated prior to the development 
of significant retinopathy, based on the 
recommendations by the Early Treatment Diabetic 
Retinopathy Study (ETDRS), lowers the risk of severe 
visual loss to less than 5% (2). Pan-retinal 
photocoagulation (PRP) is currently the mainstay of 
treatment for proliferative retinopathy (3,4). 
 
The therapeutic effects of PRP rely on the destruction 
of the outer retina, which helps reduce oxygen demand 
while maintaining a constant oxygen input. Laser 
burns may also serve as physiological windows 
through which oxygen diffuses from the choroid, 
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increasing vitreous oxygenation and induced 
vasoconstriction (3). The energy of a conventional 
argon laser is transformed to heat at the level of the 
retinal pigment epithelium (RPE) and the outer retinal 
layer. However, longer laser wavelengths will 
penetrate deeper than the RPE and cause more 
destructive changes to the retina, RPE, and 
choriocapillaris (5). 
 
Optical coherence tomography (OCT) is a modern 
biomicroscopic imaging technique widely used to 
obtain high-resolution cross sectional images of the 
retinal layers. It resembles an optical biopsy and 
provides images in real time. OCT assists clinicians in 
observing macular changes as well as assessing the 
status of optic nerve damage in glaucoma by looking 
at peripapillary retinal nerve fibre layer (RNFL) 
thickness (6). Therefore,it is important for the clinician 
to be aware of conditions that predispose to abnormal 
RNFL thickness, such as PRP. 
 
Many studies have reported variable findings with 
respect to possible changes in the RNFL following 
PRP (5,7). For instance, Lim et al. in a cross sectional 
study, described significant thinning of the inferior and 
nasal RNFL in post-PRP eyes (7). Conversely, in 
another retrospective study by Kim and Cho in the 
Korean Journal of Ophthalmology, reported that there 
was no significant relationship between treatment and 
the control group (5). The present study aimed to 
longitudinally evaluate peripapillary RNFL changes 
after PRP in our populationusing the OCT which is 
more objective and to look at the possible association 
between RNFL and blood sugar control, in particular 
HbA1c levels. 
 
Materials and Methods 
 
This is a prospective longitudinal study conducted in 
Universiti Kebangsaan Malaysia Medical Center 
(UKMMC), Kuala Lumpur, Malaysia. It was 
conducted between July 2010 and May 2013. The 
participants of this study were patients diagnosed with 
proliferative diabetic retinopathy (PDR) and very 
severe non-(N) PDR who required laser treatment. An 
experienced ophthalmologist graded the stages of 
diabetic retinopathy clinically and diagnosis was made 
based on the ETDRS classification recommendation. 
Ethical approval was obtained from the Research and 
Ethical Committee of UKMMC. 
 
Inclusion criteria were: patients with type 2 diabetes 
mellitus with very severe NPDR (ETDRS 
classification) or PDR, clear media without clinically 
significant cataract, age of diagnosis of diabetes 
mellitus >35 years of age and good signal strength of 
more than five on time-domain OCT. Exclusion 
criteria were Type 1 diabetes mellitus, media opacity, 
such as significant ocular media complications (which 
precluded good OCT images), eyes with co-existing 
glaucomatous optic disc changes, previous surgery, 
degenerative myopia, uveitis, and other retinal 
vascular pathology that may affect RNFL thickness. 
Written consent was obtained from all participants. 
Examination involved visual acuity, anterior segment 
evaluation, fundus photography, and peripapillary 
RNFL evaluation using time-domain OCT (Carl Zeiss 
Meditec Inc., Dublin, CA, USA). HbA1c levels of 
every patient were also recorded.  
 
PRP was performed by single trained personnel. An 
argon green 532 nm (Ellex SOLITAIRE, FL, USA) 
laser machine was used. A total of 900 to 1200 laser 
spots were required for each setting. Spot size was 200 
µm and pulse duration 100 milliseconds. Power was 
adjusted to attain grey burns and spots were placed one 
spot distance apart. Repeated PRP lasering was 
performed in two to four sessions until the new vessels 
regressed. Fundus was reviewed by another qualified 
observer to determine the sufficiency of treatment. 
Intervals between the laser sessions were fixed at 1 to 
2 weeks. The total laser spots over the entire treatment 
period ranged from 2,000 to 2,500 shots. Repeat OCT 
was performed 2 and 4 months after treatment. 
 
Peripapillary RNFL measurements were obtained 
using optical coherence tomography (Stratus OCT3, 
Carl Zeiss Meditech). Through a dilated pupil, a 3.4 
mm diameter ring was centred around the optic nerve 
head and 768 A-scans were acquired using the fast 
RNFL thickness protocol. The peripapillary regions 
assessed included temporal (316°–45°), superior (46°–
135°), nasal (136°–225°), and inferior (226°–315°). In 
clock-hour positions, 3 o’clock was considered 
temporal; 6 o’clock, inferior; 9 o’clock, nasal; and 12 
o’clock, superior. The average thickness (360°) was 
also measured. 
 
Statistical Analysis  
 
Statistical analyses in this study were presented 
descriptively. Univariate, bivariate, and multivariate 
analyses were performed using the Statistical Package 
for Social Sciences (SPSS) version 20.0 (IBM Corp, 
Armonk, NY, USA). Paired t-test was used for normal 
data and Wilcoxon sign ranked test for data not 
normally distributed. A P-value of less than 0.05 was 
considered statistically significant. 
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Table 1: Summary of the demographic data and clinical characteristics of the study population 
 
Variable 
Patients 
N (N = 39) 
Percentage 
(%) 
Age (Years) (n, %)   
Mean (SD) 54.97 ± 8.381  
Gender (n, %)   
Male 18 46.2 
Female 21 53.8 
Ethnicity (n, %)   
Malay 
Chinese  
Indian 
23 
14 
2 
59.0 
35.9 
5.1 
HbA1c level (n, %)   
<6.5% 4 10.3 
6.5- 8.0% 17 43.6 
8.0-10.0% 9 23.1 
>10.0% 9 23.1 
Diabetic retinopathy type (n, %)   
PDR 29 74.3 
Very severe NPDR 10 25.6 
 
Table 2:  Peripapillary RNFL thickness for each quadrant pre- and post-PRP treatment. Baseline value was RNFL thickness 
measured prior to PRP treatment and followed by the RNFL thickness measurements 2 and 4 months after PRP treatment 
 
Peripapillary area 
RNFL thickness 
(median ± interquantile range, µm) 
P-value 
Baseline 2 months 4 months P-value1 P-value2 
Superior (µm) 138.0±37.0 140.0±33.0 137.0±29.0 0.157 0.46 
Nasal (µm) 77.0±38.0 84.0±26.0 77.0±24.0 0.663 0.75 
Inferior (µm) 139.0±50.0 137.0±44.0 133.0±40.0 0.057 0.23 
Temporal (µm) 81.0±23.0 89.0±24.0 87.0±27.0 0.017 0.06 
Average (µm) 108.8±35.3 117.4±28.6 111.0±30.8 0.006 0.065 
P-value1: for the first interval; from baseline to month 2; 
P-value2: for the second interval; from baseline to month 4;  
Significant when P < 0.05, 
 
Results 
 
Demographics 
 
A total of 50 eligible subjects were initially recruited 
at the beginning of the study. Only one eye from each 
subject was chosen. However, 11 PDR subjects had to 
be excluded during the study due to development of 
vitreous haemorrhage (3), poor OCT signal (2), 
defaulted follow-up (5), and deceased (1). Only 39 
subjects completed the review and were analysed at 
the end of the study. In total, 29 patients had PDR and 
10 patients had very severe non-PDR. Mean age was 
54.97 ± 8.38 years, and there were 18 males and 21 
females. The majority subjects had suboptimal sugar 
control, as HbA1c was within the range of 6.5% to 
8.0% and this accounted for 43.6% of the recruited 
subjects. The remaining 46.2% presented with HbA1c 
levels of >8.0% (Table 1). 
 
Peripapillary Retinal Nerve Fibre Layer Thickness 
  
The subjects were not normally distributed; non-
parametric analysis was used. Baseline RNFL thickness 
according to quadrant were: Superior 138.0 ± 37.0 µm, 
nasal 77.0 ± 38.0 µm, inferior 139.0 ± 50.0 µm, and  
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Figure 1: Peripapillary RNFL thickness changes (according to quadrant) before and after argon laser treatment. Transient 
thickening occurred month 2 post-treatment. Normalisation of the RNFL in all quadrants at 4 months. 
 
temporal 81.0 ± 23.0 µm, with an overall average of 
108.8 ± 35.3 µm. There was an increase in the average 
RNFL thickness two months post-treatment.  
 
Median thickness for average RNFL was 108.8 µm 
(interquartile range [IQR] 35.3) at baseline, which 
increased to 117.4 µm (IQR 28.6) after treatment (P = 
0.006). However, there was mild decrease in average 
RNFL thickness from 117.4 µm (IQR 28.6) at 2 
months to 111.0 µm (IQR 30.8) at 4 months, which 
was not statistically significant (P = 0.065). The 
overall average RNFL change from baseline to 4 
months was also not statistically significant, P = 0.65. 
Baseline superior RNFL thickness, and at month 2 and 
month 4 was 138.0 ± 37.0 µm, 140.0 ± 33.0 µm (P = 
0.157) and 137.0 ± 29.0 (P = 0.46), respectively. Nasal 
RNFL: 77.0 ± 38.0 µm, 84.0 ± 26.0 µm (P = 0.663), 
and 77.0 ± 24.0 µm (P = 0.75); inferior RNFL: 139.0 ± 
50.0 µm, 137.0 ± 44.0 µm (P = 0.057), and 133.0 ± 
40.0 µm (P = 0.23); temporal RNFL; 81.0 ± 23.0 µm, 
89.0 ± 24.0 µm (P = 0.017), and 87.0 ± 27.0 µm (P = 
0.06), at baseline and 2 and 4 months post-treatment, 
respectively (Table 2, Fig. 1). 
 
Changes in average RNFL were only significant at 2 
months post-treatment. Therefore, analysis was done 
using Kruskal-Wallis test looking at a possible 
association between the changes in RNFL and HbA1c 
levels. However, no significant association was found 
between change in RNFL thickness and the level of sugar 
control for the past 3 months. Mean rank for Group 1 
(HbA1c <6.5%) was 24.13; Group 2 (HbA1c of 6.6%–
8.0%) was 17.56; Group 3 (HbA1c of 8.1%–10.0%) was 
27.56; and Group 4 (HbA1c >10.1%) was 15.22. 
 
Discussion 
 
This study demonstrated transient RNFL thickening in 
all quadrants, which occurred during the first two 
months after PRP. Significant changes were 
demonstrated for average RNFL. Although, other 
quadrants did not reach statistically significant 
differences, a consistent thickening trend was observed 
in all quadrants. Ritenour et al. reported, in his small 
study of 10 patients (8), thickening of RNFL (higher in 
the temporal quadrant) was also observed at 2 month 
post-laser and regression to baseline value occurred at 
6 months post-treatment. Similar findings were 
described by Kim et al. in which significant transient 
thickening peaked at 1 month post-treatment with 
further gradual reduction of RNFL thickness after 12 
months (9).This transient retinal thickening was most 
likely due to post-laser inflammatory effects. An 
animal study by Nonaka et al. suggested that PRP 
increases leucocyte rolling and aggravation in blood 
vessels. This leucocyte-endothelial reaction further 
contributes to the increase in retinal vessel 
permeability, which results in retinal swelling post-
laser treatment (10). 
 
Our study showed recovery of RNFL thickening fairly 
early compared to other studies (9,11). At four months 
post-treatment, RNFL in all quadrants recovered to 
almost baseline values; there were no significant 
differences in any quadrants with respect to baseline 
thickness and four months post-treatment. In other 
studies, recovery of retinal oedema only occurs at six 
months (9,11).  Findings of further changes in the 
peripapillary RNFL during the latent phase of 
treatment are variable. For instance, a cross sectional 
study by Lim et al. reported significant thinning of the 
RNFL post-laser compared to the normal population 
(7). Lee et al. reported similar findings in their 
prospective longitudinal study conducted over two 
years (11).Conversely, Kim et al. did not find 
significant thinning in their study population over a 1 
year follow-up; RNFL gradually reduced, but was not 
less than baseline values (9). We also found 
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insignificant differences between baseline RNFL and 
the final thickness at the end of our study. We believe 
that a longer observation period will provide more 
valuable information regarding RNFL changes.  
 
The objective and reproducible results of OCT 
imaging provides another platform for glaucoma 
assessment (12). Importantly, OCT has also been used 
to diagnose pre-perimetric glaucoma (13). 
Interestingly, Lim et al. highlighted that optic nerves 
post-PRP tend to be graded as abnormal although 
clinically they do not appear glaucomatous. 
Furthermore, they described a significant association 
between thin RNFL and clinically abnormal discs (7). 
Therefore, it is important for the clinician to be aware 
of conditions predisposing patients to abnormal RNFL 
thickness and evaluation of glaucoma must be made 
with caution. 
 
In patients with diabetes, high blood HbA1c suggests 
poor blood sugar control, which might threaten tissue 
viability, which in turn theoretically makes the RNFL 
vulnerable to external insults, such as laser. However, 
this vulnerability did not translate into further damage 
to RNFL thickness post-laser treatment in our study. 
Poor diabetic control, as defined by HbA1c level, did 
not increase the risk of further RNFL changes 
immediately post-PRP. Interestingly, this association 
has never been highlighted in other studies and we 
believe that this should be further evaluated with more 
specific outcomes. 
 
Limitations to this study include its short follow-up. 
However, within the study period, we managed to 
highlight the important observation of RNFL changes 
and relate our findings to many previous reports. A 
longer observation period will provide more details on 
the long term changes with relation to time. Secondly, 
time-domain OCT is an earlier version of tomography. 
Although the cellular detail is not as great as with the 
newer spectral domain OCT, RNFL thickness 
measurements using time-domain OCT are as good as 
the newer imaging techniques.  
 
In conclusion, PRP causes transient thickening, 
particularly in the temporal RNFL. Therefore, the use 
of RNFL imaging for glaucoma diagnosis in this 
patient population must therefore be made with 
caution. At the same time, poor sugar control has no 
direct influence on the RNFL changes after PRP. 
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